文献速递心律失常

植入式心律转复除颤器的发展:JACC历史性突破回顾

Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

本文回顾了植入式心律转复除颤器(ICD)从先驱Mirowski和Mower的构想至成为心血管医学重大进展的历程。1980年自动终止心室颤动的关键患者实验促成FDA批准,经静脉导线系统将ICD从开胸二级预防转为一级预防,前瞻性随机对照试验证实其降低死亡率优于抗心律失常药物,并扩展至遗传性心律失常。

要点

  • ICD是50年来心血管医学最重大进展之一,源于先驱在质疑中坚持创新。
  • 1980年自动终止心室颤动的关键实验促成FDA批准。
  • 经静脉导线系统使ICD从开胸二级预防转为一级预防。

核心结论

  • ICD的发展证明,凭借无畏想象力追求与公认智慧冲突的新思路,医学可能取得重大进步。

研究设计与样本

  • 本文为历史回顾性综述,追溯ICD从概念到临床应用的突破历程。

主要发现

  • 1980年自动终止心室颤动的关键患者实验促成FDA批准。
  • 经静脉导线系统将ICD从开胸二级预防转为一级预防。
  • 前瞻性随机对照试验显示ICD降低死亡率优于抗心律失常药物。
  • ICD适应证从冠心病扩展至遗传性心律失常(如肥厚型心肌病)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Implantable cardioverter-defibrillators (ICDs) represent transformational technology, arguably the most significant advance in cardiovascular medicine in 50 years. The vision and determination of pioneers Mirowski and Mower was fundamental to this monumental achievement, working with limited resources and confronted by skepticism/criticism from medical establishment. The inventors were followed >35 years in which a multitude of innovative clinical scientists and engineers introduced technological advances leading to the sophisticated devices in practice today. A pivotal patient experiment with automated termination of ventricular fibrillation (1980) led to U.S. Food and Drug Administration approval. Transvenous lead systems converted ICDs from thoracotomy-based secondary prevention to primary prevention of sudden death devices in countless patients worldwide. ICD acceptance was solidified by prospective randomized controlled trials showing reduced mortality superior to antiarrhythmic drugs. ICDs eventually expanded from coronary disease to inherited arrhythmia conditions (eg, hypertrophic cardiomyopathy). The ICD breakthrough story demonstrates how significant progress is possible in medicine against all odds, given fearless imagination to pursue novel ideas that conflict with accepted wisdom.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Maron BJ, Estes NAM, Rowin EJ, et al. Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective. J Am Coll Cardiol. 2023. PMID: 37468191. doi:10.1016/j.jacc.2023.04.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。